Following recent media stories concerning high dosages of vitamin E,
the National Eye Institute has reviewed the 2001 findings of the
Age-Related Eye Disease Study (AREDS), a study of nearly 5,000
patients with varying stages of age-related macular degeneration
(AMD) a leading cause of vision loss. Both the AREDS results
regarding the risks and benefits of taking vitamin E and the results
of multiple other published studies of vitamin E were reviewed.
A
paper to be published in the January 2005 edition of the
Annals of Internal Medicine will report that taking high-dose
vitamin E supplements does not lower the risk of death, and there
might be a small increase in the risk of death. The material in
this paper was recently presented at a meeting of the American
College of Physicians in New Orleans and this presentation has
received much attention from the media. The authors of the paper
analyzed combined data from 19 clinical trials that had tested
vitamin E as a possible treatment for different diseases. One of the
trials included in the analysis was the AREDS. In the AREDS,
scientists found that people at high risk of developing advanced
stages of AMD could lower their risk of the disease by about 25
percent when treated with a high-dose combination of vitamin C,
vitamin E, beta-carotene, and zinc.
After careful study and interpretation of the data from the paper in
Annals of Internal Medicine, the NEI researchers have
concluded that taking a recommended 400 international units (IU) of
vitamin E each day, as part of the AREDS formulation, does not
increase the risk of death of persons at risk for advanced AMD.
"If the reason for taking vitamin E is to decrease mortality, we
agree with the authors of this new study that there does not seem to
be any benefit of vitamin E for most patients and there might be
some harm at very high doses of 500 IU or more," Emily Chew, M.D.,
deputy director of the Division of Epidemiology and Clinical
Research at NEI. "However if you are at high risk for developing
AMD, there is a benefit in taking the AREDS formulation that
includes vitamin E. Different patients have different needs and it
is important to discuss with your doctor whether this formulation is
right for you," says Dr. Chew.
In
the new study, the data seem to show that people taking particularly
high doses of vitamin E (500 IU to 2000 IU) may have a slightly
increased risk of death. However, taking 400 IU vitamin E per day
did not increase the risk of death in a total of 15,000 patients
studied in several different clinical trials.